Literature DB >> 21750208

Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.

Darya V Urusova1, Jung-Hyun Shim, Dong Joon Kim, Sung Keun Jung, Tatyana A Zykova, Andria Carper, Ann M Bode, Zigang Dong.   

Abstract

The most active anticancer component in green tea is epigallocatechin-3-gallate (EGCG). The human peptidyl prolyl cis/trans isomerase (Pin1) plays a critical role in oncogenic signaling. Herein, we report the X-ray crystal structure of the Pin1/EGCG complex resolved at 1.9 Å resolution. Notably, the structure revealed the presence of EGCG in both the WW and PPIase domains of Pin1. The direct binding of EGCG with Pin1 was confirmed and the interaction inhibited Pin1 PPIase activity. In addition, proliferation of cells expressing Pin1 was inhibited and tumor growth in a xenograft mouse model was suppressed. The binding of EGCG with Arg17 in the WW domain prevented the binding of c-Jun, a well-known Pin1 substrate. EGCG treatment corresponded with a decreased abundance of cyclin D1 and diminution of 12-O-tetradecanoylphorbol-l3-acetate-induced AP-1 or NF-κB promoter activity in cells expressing Pin1. Overall, these results showed that EGCG directly suppresses the tumor-promoting effect of Pin1. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750208      PMCID: PMC3244823          DOI: 10.1158/1940-6207.CAPR-11-0301

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  45 in total

1.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 2.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.

Authors:  Kun Ping Lu; Xiao Zhen Zhou
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

Review 3.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

4.  Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.

Authors:  Gerburg M Wulf; Yih-Cherng Liou; Akihide Ryo; Sam W Lee; Kun Ping Lu
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

5.  (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.

Authors:  Svetlana P Ermakova; Bong Seok Kang; Bu Young Choi; Hong Seok Choi; Todd F Schuster; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

6.  The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.

Authors:  M Shen; P T Stukenberg; M W Kirschner; K P Lu
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

7.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.

Authors:  Gerburg Wulf; Priti Garg; Yih-Cherng Liou; Dirk Iglehart; Kun Ping Lu
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

9.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  Structural basis for high-affinity peptide inhibition of human Pin1.

Authors:  Yan Zhang; Sebastian Daum; Dirk Wildemann; Xiao Zhen Zhou; Mark A Verdecia; Marianne E Bowman; Christian Lücke; Tony Hunter; Kun-Ping Lu; Gunter Fischer; Joseph P Noel
Journal:  ACS Chem Biol       Date:  2007-05-22       Impact factor: 5.100

View more
  30 in total

Review 1.  Notes from the field: "green" chemoprevention as frugal medicine.

Authors:  Jed W Fahey; Paul Talalay; Thomas W Kensler
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

Review 2.  Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.

Authors:  Jane A Driver; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2015-01-10

3.  Effects of Tea Catechins on Cancer Signaling Pathways.

Authors:  Chung S Yang; Hong Wang; Jayson X Chen; Jinsong Zhang
Journal:  Enzymes       Date:  2014

4.  Neighboring phosphoSer-Pro motifs in the undefined domain of IRAK1 impart bivalent advantage for Pin1 binding.

Authors:  Monique J Rogals; Alexander I Greenwood; Jeahoo Kwon; Kun Ping Lu; Linda K Nicholson
Journal:  FEBS J       Date:  2016-11-20       Impact factor: 5.542

Review 5.  Lessons learned from cancer prevention studies with nutrients and non-nutritive dietary constituents.

Authors:  Chung S Yang; Jayson X Chen; Hong Wang; Justin Lim
Journal:  Mol Nutr Food Res       Date:  2016-05-09       Impact factor: 5.914

Review 6.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 7.  Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.

Authors:  Chung S Yang; Jinsong Zhang; Le Zhang; Jinbao Huang; Yijun Wang
Journal:  Mol Nutr Food Res       Date:  2015-12-09       Impact factor: 5.914

8.  Cancer therapy combination: green tea and a phosphodiesterase 5 inhibitor?

Authors:  Chung S Yang; Hong Wang
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

Review 9.  Cancer prevention by tocopherols and tea polyphenols.

Authors:  Chung S Yang; Guangxun Li; Zhihong Yang; Fei Guan; Amber Chen; Jihyeung Ju
Journal:  Cancer Lett       Date:  2013-02-08       Impact factor: 8.679

Review 10.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.